AbbVie Inc. Annual Income Tax Expense (Benefit) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
AbbVie Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2011 to 2023.
  • AbbVie Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2024 was $773M, a 32.6% increase year-over-year.
  • AbbVie Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2024 was $1.72B, a 2.39% decline year-over-year.
  • AbbVie Inc. annual Income Tax Expense (Benefit) for 2023 was $1.38B, a 15.6% decline from 2022.
  • AbbVie Inc. annual Income Tax Expense (Benefit) for 2022 was $1.63B, a 13.3% increase from 2021.
  • AbbVie Inc. annual Income Tax Expense (Benefit) for 2021 was $1.44B.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.38B -$255M -15.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-20
2022 $1.63B +$192M +13.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-20
2021 $1.44B +$2.66B Jan 1, 2021 Dec 31, 2021 10-K 2024-02-20
2020 -$1.22B -$1.77B -325% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 $544M +$1.03B Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 -$490M -$2.91B -120% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 $2.42B +$487M +25.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $1.93B +$430M +28.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-27
2015 $1.5B +$906M +152% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 $595M -$609M -50.6% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 $1.2B +$754M +168% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $450M +$215M +91.5% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-20
2011 $235M Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.